Investor Relations

Corporate Overview

Shuttle Pharmaceuticals (Nasdaq: SHPH) is a clinical-stage pharmaceutical company leveraging our proprietary technology to develop novel therapies that are designed to cure cancer. Led by a best-in-class management team with significant experience in cancer treatment, we are developing a pipeline of revolutionary radiation sensitizers and immunotherapy assisting product candidates.

Latest News

Recent Presentation

Recent Events

Featured Videos

Investor Contact Information


Shuttle Pharmaceuticals
1 Research Court, Suite 450
Rockville, MD 20850
Phone: 240-403-4212


Investor Relations

Lytham Partners, LLC
Robert Blum
Phone: 602-889-9700


Transfer Agent

Vstock Transfer, LLC
18 Lafayette Place
Woodmere, NY 11598
Phone: 212-828-8436
Toll-Free: 855-9VSTOCK
Fax: 646-536-3179


Skip to content